Sanjay Gandhi to Myocardial Infarction
This is a "connection" page, showing publications Sanjay Gandhi has written about Myocardial Infarction.
Connection Strength
1.392
-
Pasala T, Hoo JS, Lockhart MK, Waheed R, Sengodan P, Alexander J, Gandhi S. Aspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery Disease. Tex Heart Inst J. 2016 Dec; 43(6):482-487.
Score: 0.411
-
Ginwalla M, Pillai D, Gandhi S. Use of intra-aortic balloon counterpulsation during emergent cesarean section in a pregnant patient with myocardial infarction. J Invasive Cardiol. 2010 Jun; 22(6):E104-6.
Score: 0.262
-
Riley RF, Newby LK, Don CW, Roe MT, Holmes DN, Gandhi SK, Kutcher MA, Herrington DM. Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: a report from the American Heart Association Mission: Lifeline program. Am Heart J. 2013 Jan; 165(1):50-6.
Score: 0.078
-
Schuetz CA, van Herick A, Alperin P, Peskin B, Hsia J, Gandhi S. Comparing the effectiveness of rosuvastatin and atorvastatin in preventing cardiovascular outcomes: estimates using the Archimedes model. J Med Econ. 2012; 15(6):1118-29.
Score: 0.076
-
Penn MS, Ellis S, Gandhi S, Greenbaum A, Hodes Z, Mendelsohn FO, Strasser D, Ting AE, Sherman W. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circ Res. 2012 Jan 20; 110(2):304-11.
Score: 0.072
-
Crowder JS, Hubble MW, Gandhi S, McGinnis H, Zelman S, Bozeman W, Winslow J. Prehospital administration of tenecteplase for ST-segment elevation myocardial infarction in a rural EMS system. Prehosp Emerg Care. 2011 Oct-Dec; 15(4):499-505.
Score: 0.071
-
Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R. Prognostic implications of vascular complications following PCI. Catheter Cardiovasc Interv. 2009 Jul 01; 74(1):64-73.
Score: 0.061
-
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. 3-year comparison of drug-eluting versus bare-metal stents. JACC Cardiovasc Interv. 2009 Mar; 2(3):231-9.
Score: 0.060
-
Applegate RJ, Graham SH, Gandhi SK, Kutcher MA, Sacrinty MT, Santos RM, Little WC. Culprit vessel PCI versus traditional cath and PCI for STEMI. J Invasive Cardiol. 2008 May; 20(5):224-8.
Score: 0.057
-
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2008 Feb 12; 51(6):607-14.
Score: 0.056
-
Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Am J Cardiol. 2007 Feb 01; 99(3):333-8.
Score: 0.051
-
Upadhya B, Applegate RJ, Sane DC, Deliargyris EN, Kutcher MA, Gandhi SK, Baki TT, Call JT, Little WC. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol. 2005 Aug 15; 96(4):515-8.
Score: 0.047
-
Deliargyris EN, Upadhya B, Applegate RJ, Kutcher MA, Gandhi SK, Sane DC. Superior in-hospital and 30-day outcomes with abciximab versus eptifibatide: a contemporary analysis of 495 consecutive percutaneous coronary interventions. J Invasive Cardiol. 2004 Nov; 16(11):611-6.
Score: 0.045
-
Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes. J Invasive Cardiol. 2010 Jun; 22(6):266-70.
Score: 0.016
-
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Circ Cardiovasc Interv. 2009 Feb; 2(1):35-42.
Score: 0.015
-
Applegate RJ, Grabarczyk MA, Sane DC, Sacrinty MT, Goodin JE, Statonk GS, Baki TT, Gandhi SK, Kutcher MA, Little WC. PCI with and without abciximab after upstream eptifibatide use: outcomes in high-risk patients. J Invasive Cardiol. 2006 Dec; 18(12):604-13.
Score: 0.013